ASP1585 Pharmacokinetic Interaction Study - Pharmacokinetic Interaction With Atorvastatin.

Trial Profile

ASP1585 Pharmacokinetic Interaction Study - Pharmacokinetic Interaction With Atorvastatin.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Aug 2010

At a glance

  • Drugs Atorvastatin; Bixalomer
  • Indications Alzheimer's disease; Atrial fibrillation; Cardiovascular disorders; Diabetic foot ulcer; Heart failure; Hypercholesterolaemia; Hyperlipoproteinaemia type II; Hyperlipoproteinaemia type III; Hyperphosphataemia; Hypertriglyceridaemia; Neurological disorders; Retinal vascular occlusion; Systemic lupus erythematosus
  • Focus Pharmacokinetics
  • Most Recent Events

    • 26 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
    • 26 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 08 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top